Skip to main content

Losartan potassium and Hydrochlorothiazide

NDC 33342-050 · Macleods Pharmaceuticals Limited

Generic nameLosartan potassium and Hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE
Strength12.5; 50 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

33342-050-07 — 30 TABLET, FILM COATED in 1 BOTTLE (33342-050-07)

33342-050-10 — 90 TABLET, FILM COATED in 1 BOTTLE (33342-050-10)

33342-050-12 — 10 BLISTER PACK in 1 CARTON (33342-050-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK

33342-050-44 — 1000 TABLET, FILM COATED in 1 BOTTLE (33342-050-44)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-887 — Olmesartan medoxomil and hydrochlorothiazide, 31722-888 — Olmesartan medoxomil and hydrochlorothiazide, 31722-892 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-893 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-894 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-895 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-896 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 33342-044 — Losartan potassium, 33342-045 — Losartan potassium, 33342-046 — Losartan potassium, 33342-051 — Losartan potassium and Hydrochlorothiazide, 33342-052 — Losartan potassium and Hydrochlorothiazide, 33342-057 — Irbesartan and Hydrochlorothiazide, 33342-058 — Irbesartan and Hydrochlorothiazide, 33342-074 — Valsartan and Hydrochlorothiazide, 33342-075 — Valsartan and Hydrochlorothiazide, 33342-076 — Valsartan and Hydrochlorothiazide, 33342-077 — Valsartan and Hydrochlorothiazide, 33342-078 — Valsartan and Hydrochlorothiazide, 33342-131 — Candesartan Cilexetil and Hydrochlorothiazide, +1060 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels